An Observational Retrospective Study Comparing Ustekinumab Versus Secukinumab in Patients with Moderate to Severe Psoriasis
Latest Information Update: 09 May 2018
At a glance
- Drugs Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 09 May 2018 New trial record